Two Sigma Investments LP Reduces Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Two Sigma Investments LP trimmed its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 30.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 83,282 shares of the company's stock after selling 36,426 shares during the quarter. Two Sigma Investments LP owned 0.17% of Prestige Consumer Healthcare worth $6,503,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC raised its position in shares of Prestige Consumer Healthcare by 346.3% in the 3rd quarter. Barclays PLC now owns 92,444 shares of the company's stock valued at $6,665,000 after purchasing an additional 71,730 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Prestige Consumer Healthcare by 18.8% in the 4th quarter. SG Americas Securities LLC now owns 5,996 shares of the company's stock valued at $468,000 after purchasing an additional 947 shares during the last quarter. Exchange Traded Concepts LLC raised its position in shares of Prestige Consumer Healthcare by 4.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 23,776 shares of the company's stock valued at $1,857,000 after purchasing an additional 975 shares during the last quarter. Blue Trust Inc. raised its position in Prestige Consumer Healthcare by 24.8% during the 4th quarter. Blue Trust Inc. now owns 2,190 shares of the company's stock worth $158,000 after buying an additional 435 shares during the last quarter. Finally, KBC Group NV raised its position in Prestige Consumer Healthcare by 28.3% during the 4th quarter. KBC Group NV now owns 2,048 shares of the company's stock worth $160,000 after buying an additional 452 shares during the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Up 0.1%

Shares of PBH stock traded up $0.05 during trading hours on Thursday, reaching $84.40. 273,513 shares of the stock were exchanged, compared to its average volume of 298,105. The business's fifty day moving average is $83.60 and its two-hundred day moving average is $82.38. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04. The firm has a market capitalization of $4.17 billion, a P/E ratio of 19.77, a P/E/G ratio of 2.69 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The firm had revenue of $296.52 million for the quarter, compared to analyst estimates of $289.36 million. During the same period in the prior year, the firm earned $1.02 earnings per share. The business's quarterly revenue was up 7.0% compared to the same quarter last year. As a group, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on PBH shares. Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Canaccord Genuity Group upped their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Oppenheimer lifted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a report on Thursday, February 13th. DA Davidson lifted their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a report on Friday, February 7th. Finally, Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $93.33.

Insider Activity at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 1,678 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the transaction, the senior vice president now directly owns 17,157 shares of the company's stock, valued at $1,544,130. This represents a 8.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.